Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology
Published: February 12, 2019
CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
Journal: Immunology
Published: March 16, 2017
Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
Journal: PloS one
Published: August 25, 2016
Showing 1-3 of 3
Last Updated: 09/26/2026